Abstract
A total of 152 non-small cell lung cancers (NSCLC) were studied retrospectively to determine the relationship between epidermal growth factor receptor (EGF-R) status and the histological type, tumour size, nodal status and prognosis. EGF-R status was assessed on routinely embedded paraffin sections with an antibody to the cytoplasmic domain of the tumour (F4 antibody). EGF was demonstrated in all tumour types and every squamous and large cell carcinoma was positive for the antibody. Most tumours showed heterogeneity of staining. EGF expression was seen statistically more frequently in well differentiated tumours. Patients with 50% or more tumour cells showing positivity tended to have an improved survival but this result failed to reach statistical significance. There was no relationship between the size of the primary tumour or the lymph node status. Other cells, such as mucinous glands, bronchial epithelial cells and macrophages stained positively with the monoclonal antibody. EGF receptor status, with the antibodies presently available, adds little to help in either diagnosis or prognosis. Interpretation of data has to be guarded since the antibody was seen in some normal cells.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dazzi, H., Hasleton, P., Thatcher, N. et al. Expression of epidermal growth factor receptor (EGF-R) in non-small cell lung cancer. Use of archival tissue and correlation of EGF-R with histology, tumour size, node status and survival. Br J Cancer 59, 746–749 (1989). https://doi.org/10.1038/bjc.1989.156
Issue Date:
DOI: https://doi.org/10.1038/bjc.1989.156
This article is cited by
-
Moderne immuntherapeutische Ansätze für die Behandlung von Lungen- und Kopf-Hals-Tumoren
Der Onkologe (2005)
-
Phosphorylated tyrosine-containing proteins in primary lung cancer correlates with proliferation and prognosis
British Journal of Cancer (2002)
-
Clinical and prognostic importance of expression of epidermal growth factor receptors in non-small-cell lung carcinoma
Bulletin of Experimental Biology and Medicine (1999)
-
The prognostic value of epidermal growth factor receptor (EGF-R) in primary breast cancer: Results of a 10 year follow-up study
Breast Cancer Research and Treatment (1994)
-
Prognostic value of a solubilized fraction of EGF receptors in primary breast cancer using an immunoenzymatic assay ? a retrospective study
Breast Cancer Research and Treatment (1994)